Launch of generic Motegrity (Prucalopride) tablets

 Generic Motegrity (Prucalopride) has recently been released and is approved by the FDA. 

Prucalopride is indicated for the treatment of Chronic Idiopathic Constipation (CIC) in adults. Chronic idiopathic constipation (CIC) is a common functional bowel disorder without a known cause, characterized by difficult, infrequent, and/or incomplete defecation.  

Prucalopride is a selective serotonin type 4 (5-HT4) receptor agonist that works by increasing rhythmic movements of the colon muscle, which increases bowel motility. 

Prucalopride is manufactured by ANI Pharmaceuticals, Inc. and is available in 1mg and 2mg tablets.